Related Experiment Video
Updated: Aug 14, 2026

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome (ARDS)
Published on: April 7, 2021
Surfactant application during extracorporeal membrane oxygenation improves lung volume and pulmonary mechanics in
Michael Hermon1, Gudrun Burda, Christoph Male
1Division of Neonatology and Pediatric Intensive Care, University Children's Hospital, Medical University of Vienna, Austria. michael.hermon@meduniwien.ac.at
Insights
Surfactant administration during extracorporeal membrane oxygenation (ECMO) in children significantly improved lung function and mechanics. This finding suggests potential benefits for respiratory support in critically ill pediatric patients.
Area of Science:
- Pediatric Critical Care Medicine
- Neonatology
- Pulmonology
Background:
- Extracorporeal membrane oxygenation (ECMO) is a life-support measure for severe respiratory failure in children.
- Optimizing lung function during ECMO is crucial for patient outcomes.
- The role of exogenous surfactant in improving respiratory mechanics during pediatric ECMO requires further investigation.
Purpose of the Study:
- To evaluate the impact of surfactant administration on lung volume, pulmonary mechanics, and radiographic findings in pediatric patients undergoing ECMO.
- To compare outcomes between children receiving surfactant during ECMO and a control group.
Main Methods:
- Retrospective chart review of pediatric patients in a pediatric intensive care unit (PICU).
- Comparison of seven patients who received surfactant (group S) with six matched controls (group C) during ECMO.
- Extraction of demographic data, ventilator settings, tidal volume, respiratory system compliance, and ECMO flow.
- Radiographic scoring by blinded radiologists and statistical analysis using repeated-measures analysis of variance.
Main Results:
- Surfactant administration in group S led to a near doubling of mean tidal volume (186.2%) and a significant increase in compliance (176.1%) compared to baseline.
- No significant changes in tidal volume or compliance were observed in the control group (group C).
- Chest radiograph scores tended to improve, and ECMO flow tended to decrease post-surfactant in group S, with no significant impact on mortality.
Conclusions:
- Surfactant application during ECMO in children with respiratory failure may improve lung function and mechanics.
- These preliminary findings suggest a potential benefit of surfactant therapy in this patient population.
- Further confirmation through prospective studies is warranted to solidify these conclusions.
Introduction:
This study was performed to determine whether surfactant application during extracorporeal membrane oxygenation (ECMO) improves lung volume, pulmonary mechanics, and chest radiographic findings in children with respiratory failure or after cardiac surgery.
Methods:
This was a retrospective chart review study in a pediatric intensive care unit (PICU). Seven patients received surfactant before weaning from ECMO was started (group S). They were compared to six patients treated with ECMO who did not receive surfactant (group C). These control patients were matched based on age, weight, and underlying diagnosis. Demographic data, ventilator settings, tidal volume, compliance of respiratory system (calculated from tidal volume/(peak inspiratory pressure - positive end-expiratory pressure), and ECMO flow were extracted. Chest radiographs were scored by two blinded and independent radiologists. Changes over time were compared between groups by repeated-measures analysis of variance (time*group interaction). Values are given as percentages of baseline values.
Results:
The groups did not differ with regard to demographic data, duration of ECMO, ventilator settings, PICU and hospital days. After application of surfactant, mean tidal volume almost doubled in group S (from 100% before to 186.2%; p = 0.0053). No change was found in group C (100% versus 98.7%). Mean compliance increased significantly (p = 0.0067) in group S (from 100% to 176.1%) compared to group C (100% versus 97.6%). Radiographic scores tended to decrease in group S within 48 h following surfactant application. ECMO flow tended to decrease in group S within 10 h following surfactant application but not in group C. Mortality was not affected by treatment.
Conclusion:
Surfactant application may be of benefit in children with respiratory failure treated with ECMO, but these findings need confirmation from prospective studies.
Related Concept Videos
Breathing
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Pulmonary Cycle: Exhalation
Factors Affecting Pulmonary Ventilation
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
Cardiopulmonary Resuscitation II: ACLS Airway Management
Respiratory Volumes
Tidal Volume (TV) Tidal volume (TV) is the air inhaled or exhaled in a...
